Kevin Stein
Analyst · Melius Research
Thanks Nick. Today, I will first provide my regular review of results by key market and profitability of the business for the quarter, and then cover outlook and some COVID-19 related topics. We are pleased with the solid Q2 results, particularly considering the increasingly difficult global economy and commercial aerospace industry. In Q2, we saw a modest unfavorable impact to our commercial aftermarket, and OEM sales for COVID-19 pandemic, as approximately last three weeks of the quarter were negatively impacted. Despite these headwinds, our second quarter operations specifically revenue and EBITDA defined expanded compared to Q2 last year, due in part to positive organic growth, as well as continuing acquisition integration and our announced preemptive cost reduction actions. Q2 GAAP revenues were up approximately 24% versus prior year Q2 and EBITDA defined was up 19% versus the prior year with margins approaching 47% of revenue. Michael will provide more details on the financials later. Now, we will review our revenues by market category. For the remainder of the call, I will provide color commentary on a pro forma basis compared to the prior year periods in 2019. That is assuming we own the same mix of businesses in both periods. Please note that this market analysis discussion includes the results of the former Esterline businesses. We began to include Esterline in this market analysis discussion in the first quarter of fiscal 2020. In the commercial market, which makes up close to 65% of our revenue, we will split our discussion into OEM and aftermarket. Our total commercial OEM market revenue declined approximately 3% in Q2, when compared with Q2 of fiscal year 2019. The decline in the quarter did reflect a minimal headwind from the impact of the ongoing 737 MAX production haltand early OEM declines related to the pandemic. It is already clear that the COVID-19 pandemic will have a significant negative impact on the commercial OEM market. We are under the assumption that the demand for commercial OEM products will be significantly reduced during the second half of fiscal 2020, due to reductions in OEM production rates and airlines deferring or canceling new aircraft orders. Longer term, the impact of COVID-19 is fluid and continues to evolve, but we anticipate significant negative impacts on our commercial OEM market for some uncertain period of time. Now moving on to our commercial aftermarket business discussion, total commercial aftermarket revenues grew by approximately 1% over the prior year quarter. In the quarter, flat commercial transport aftermarket was driven by stronger growth in passenger and interior submarkets, offset by a decline in the commercial transport freight market. Our quarterly commercial aftermarket bookings were down over 10% versus prior year quarter. Most of the decline came in March of this year, but likely does not paint the correct picture for the remainder of the fiscal year, as we expect a sharper decline in the second half. There was a rapid into dramatic decline in demand for air travel during our Q2, as global restrictions on business and shelter in place orders went into effect in response to COVID-19. This led to a significant reduction in global flight capacity and parked aircraft across the world. To hit a few of these points, global revenue passenger miles are at unprecedented lows as a result of the COVID-19 pandemic. IATA recently forecast the 48% decrease in revenue passenger miles in calendar year 2020 compared to 2019. For cargo demand, this was already weaker prior to the COVID-19 crisis as STKs have declined from reaching an all-time high in 2017. However, a loss of passenger belly cargo due to COVID-19 flight restrictions could provide some unexpected opportunities. Business jet utilization data was already pointing to stagnant growth before this economic downturn, so now during this pandemic and in the aftermath, the outlook for business jets is more unpredictable and certainly weaker. As the COBIT 19 situation is ongoing, the duration and severity of the pandemic are still unclear and long-term impacts for the commercial aftermarket are hard to predict. Now let me speak about our defense market, which is just over 35% of our total revenue. The defense market which includes both OEM and aftermarket revenues was about flat compared to the prior year Q2. As a reminder, we are lapping tougher prior year comparisons as our defense revenue accelerated in most of the fiscal 2019. Year-to-date, defense bookings have surpassed our expectations driven primarily by very robust defense OEM booking growth. Total defense booking as solidly outpaced year-to-date sales although bookings grew across most of the businesses, APKWS and parachute-related bookings were especially strong in the quarter. With continued good order flow and defense, we anticipate any favorable trends in immediate future will come from this segment. Now moving to profitability, I'm going to talk primarily about our operating performance for EBITDA as defined. EBITDA as defined of about 675 million for Q2 was up 19% versus prior Q2. EBITDA defined margin in the quarter was just under 47%. Our EBITDA as defined margin expanded both sequentially and over the prior year period, as a result of our cost mitigation efforts, any consistent focus on our operating strategy. Excluding Esterline, margins in our legacy business improves both sequentially as well as over prior year quarter. On Esterline we are now over a year post-close. The integration continues to progress and to date the acquisition is exceeding our expectations for growth in this largest of TransDigm acquisitions. As we have stated in the past, we will now no longer refer to any specific metrics as these businesses have now become part of the fabric of TransDigm. Now moving to the second half 2020. In light of the uncertainty around the ultimate impact of COVID-19 on global market and economic conditions and the highly fluid commercial aerospace industry, we still feel it is too early to provide forward looking guidance at the current time. As Nick said, once we have a better picture we will reinstitute guidance. However, I wanted to provide a bit more detail on the end market conditions. We assumed for the second half of our fiscal 2020. This is not guidance. We always have a bias to act quickly and right size the cost structure when required, when completing the organizational rightsizing analysis that drove the reduction in force levels implemented to date, we assume the following with regard to the organization sizing needs for the second half of fiscal 2020, again, organization sizing. Commercial aftermarket declines of approximately 70% to 80%, commercial OEM declines of 25% to 40%, and defense growth in the mid single digit, which is in line with our prior guidance for the defense end market. Next, I would like to review our COVID-19 response and expectations in more detail. As mentioned, we currently expect COVID-19 to have a significant adverse impact on our sales, EBITDA as defined a net income for the second half of fiscal 2020. Under the assumption that the COVID-19 outbreak will negatively impact our non-defense customers and their demand for our products and services during the second half of fiscal 2020 particularly in the commercial aftermarket. As Nick said earlier, we remain confident in our business model over the long-term and are focused on mitigating the impact of COVID-19 to our business while supporting customers and employees. Since the early days of the outbreak, we have been following guidance from the World Health Organization and the U.S. Center for Disease Control to protect employees and prevent the spread of the virus within all of our facilities globally. Some of the actions implemented include flexible work-from-home scheduling, alternate shift schedules, pre-shift temperatures screenings were allowed by law, social distancing, appropriate PPE, facilities deep cleaning and paid quarantine time for impacted employees. Most of our facilities remain in operation, even if some are operating and reduced levels, as they are deemed essential businesses by government entities since we are the sole provider for many programs, including critical defense platforms. We are committed to preserving the health and safety of our employees, while continuing to meet our customer commitments. In an effort to assist in the fight against COVID-19, certain of our businesses have begun producing medical equipment that is critically needed during the global pandemic. Our AmSafe Restraints business is producing respirators and surgical gowns, while Mason is producing face shields. We are grateful for this ability to contribute to the fight against COVID-19. Now before we move to specific cost cutting measures that Nick mentioned, it is important to understand that we view a very high percent of our costs as variable. Cost meaning revenue less EBITDA. Roughly half of our spending is related to materials including production materials or subcontractor services that are production related including plating, painting and machining. Those costs should largely flex with volumes. The next big bucket is people and benefits or direct items related to employment and is more than one third, but less than 40% of our costs. And the remaining 10% to 15% of costs include all other. We monitor these costs closely and as such let me highlight some specific class savings actions we have taken in response to the reduced demand and uncertainty resulting from the COVID-19 pandemic. These cost mitigation efforts were previously the disclosed but worth reviewing and additional reduction in force to align operations with customer demand. These actions are incremental to the cost mitigation efforts previously implemented in the second quarter of fiscal 2020, mainly in response to 737 MAX production rate changes and bring our total workforce reductions since our last earnings call to approximately 22% to 25% versus planned headcount levels. Furloughs, we're implementing a 1 to 8 week furloughs at many businesses over the next six months in response to specific situations. And substantially reducing cash compensation for the senior management team for the balance of fiscal 2020 and the Board of Directors will forego their annual retainer fees. We will continue to vigilantly monitor our operations and external events and keep the market updated on developments as appropriate. Excuse me. So let me conclude by stating. I am pleased with the speed at which TransDigm has responded to the COVID-19 pandemic, taking immediate actions to protect employees from the spread of the virus while also dealing with the harsh reality confronting the broader commercial aerospace industry in the near term. While the actions that the current circumstances require, ranging from broad cost reductions to furloughs, and a rightsizing of the employee base are difficult to implement, I have no doubt that we will better position the Company to endure and emerge more strongly from the ongoing weakness in our primary commercial end markets. With that, I'll now turn it over to our Chief Financial Officer, Michael Lisman.